Daniel Van Plew

2020

In 2020, Daniel Van Plew earned a total compensation of $8.7M as Executive Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$938,872
Option Awards$3,459,499
Salary$825,577
Stock Awards$3,409,560
Other$20,945
Total$8,654,453

Van Plew received $3.5M in option awards, accounting for 40% of the total pay in 2020.

Van Plew also received $938.9K in non-equity incentive plan, $825.6K in salary, $3.4M in stock awards and $20.9K in other compensation.

Rankings

In 2020, Daniel Van Plew's compensation ranked 1,047th out of 13,090 executives tracked by ExecPay. In other words, Van Plew earned more than 92.0% of executives.

ClassificationRankingPercentile
All
1,047
out of 13,090
92nd
Division
Manufacturing
369
out of 5,621
93rd
Major group
Chemicals And Allied Products
127
out of 2,254
94th
Industry group
Drugs
111
out of 1,954
94th
Industry
Pharmaceutical Preparations
81
out of 1,459
94th
Source: SEC filing on April 23, 2021.

Van Plew's colleagues

We found four more compensation records of executives who worked with Daniel Van Plew at Regeneron Pharmaceuticals in 2020.

2020

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2020

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2020

Andrew Murphy

Regeneron Pharmaceuticals

Executive Vice President, Research

2020

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

News

You may also like